Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
AEZS management got to prove itself; pathetic sales numbers of its only product Macrilen do not give confidence to market what they had developed so far.,.
That will be very bad if we get another delisting notice!
What had been past record of getting FDA approval by this university of Wurzburg…?
Not true. Some Pharma stock is green, like MRNA.
$0.66..
Pre-market price keeps falling…a company of 30 years with price still falling!
What kind of news you would expect? FDA approval on phase I trial?
Trading volume more than 1 million each day, price keeps falling to $0.7. Quite dangerous.
Any success story of the product development by University of Wurzburg in the past? Covid pill candidate came from this university….
Very bad. Stock only hope on one good news that may or may not come..
I hate people earn their profit by shorting stock! They need to be squeezed! If the sell is investors selling their holdings, I hold the management responsibility doing their job very badly!
Stock just has hope on news, products not selling, very bad.
Share price now 0.78… is it going down back to 0.4?
Very painful and very bad!
Another 3% drop.. very bad.
Who placed an ask price of $899? Is this realistic price?
My recent physical health is going south.. I am afraid I can’t see fruition of catalysts…
If this is talking about Q4 or even next year, this is torture to me indeed. Just stuck there bleeding is not good at all.
Very bad.. catalysts have no news at all for quite a time..
Phase 3 targets to complete next Sep. The 3 therapeutics are still in preclinical with universities. Oral covid vaccine is also in preclinical. I am afraid AEZS share price will still be under pressure even those 4 preclinicals start phase I…what’s your view on timeline on share price?
I hope what you guys said come true by end of the month. I hope we are not like gambling on the catalysts one day can come true. I am afraid no news until Q2 next year for the first catalyst. AEZS out of 30 years came out only one product and it is bad that it sells badly.
AEZS changed from development of AGHD / CGHD test to developing tbi / cancer drug and then to oral covid pill—-this is a big unbelievable change. Too good to believe..
I still don’t understand why the university gives the oral covid pill to AEZS to do clinical trials and not gives to other big pharmaceuticals? Big pharmaceuticals had more resources as well as future sales network…
I still don’t understand why the university gives the oral covid pill to AEZS to do clinical trials and not gives to other big pharmaceuticals? Big pharmaceuticals had more resources as well as future sales network…
And it will take how many years for clinical trial on oral covid pill? How can AEZS compete with those big Pharmas on launching their oral covid pill? It looks future for AEZS is quite gloomy…
Phase 3 tentative completion date is Sep 2024…so, what catalysts going to have result in Q3 this year? When to expect Oral covid pill approval for clinical trial?
What makes you so positive on this? AEZS has only history of developing diagnosis test - not even a drug that is curing diseases. Phase 3 is also on diagnosis test.,.
Yes, still half having loss..
Very regret I haven’t sold out all AEZS stock at $3. Now I can only sit here and wait for news which not sure when will come, and not sure whether it helps pumping this stock price.
The licensing deal had generated very small revenue, far less than expectation. This is very bad, demonstrating how good the first product is… why the product is not selling well…? This makes the market questioning what revenue it could generate for other catalysts..
AEZS management has no clue how to help the share price up… share price keeps falling which is torture to shareholders..
I hope this is not just a false hope. SP keeps drifting down, we need good news ASAP.
I hope this comes true ASAP. This is torture to see price below $1 for so long whereas it is said to have many catalysts …
11 employees company… I am afraid not going to have successful products produced at all…can only count on some pr pushing the share price up..
Very bad indeed. Can only hope for pr on covid pill and then time to sell off this stock…
Phase 3 result in 2023…share price before that will be very pathetic then.
Very bad, I should have sold all at $3 in March !
Any more squeeze up current price? Or shorts will win at the end?
Macrilen product sale through Novo Nordisk is pathetic. This is the reason on poor management creditability.
The issue is that AEZS does not own the product at all…